Bloomberg title Breast Cancer: Breast cancer survivors will be out $200 billion article Breast cancer sufferers will be the biggest beneficiaries of the upcoming Breast Cancer Support Act, according to a study from the University of Michigan that will be presented at a conference in the United States next week.
The study found that a typical woman with breast cancer who received the benefit in 2020 would have a life expectancy of more than eight years.
The average life expectancy for the average woman with an undetectable cancer is about five years, according the study published in the journal Breast Cancer Research and Treatment.
“A life expectancy with breast, ovarian and ovarian cancer is more than four years,” said lead author Dr. James S. Pritchard, a University of Miami medical researcher and a professor of medicine and epidemiology.
Pritchard said the study does not consider the cost of treating a breast cancer patient.
In fact, the authors estimate that the cost would be about $150 billion in 2020.
But if breast cancer sufferer are allowed to keep their current benefits, the number of people living with breast or ovarian cancer would drop by about 7.6 million, according S&P Dow Jones Indices.
The findings were published Monday in the Journal of the American Medical Association, the second study to be released Monday to support the legislation.
“The legislation will make a huge difference for women with breast and ovarian cancers, which are among the most common cancers in the U.S.,” said Jessica Dickey, senior vice president of public policy at the National Breast Cancer Coalition.
The legislation is aimed at preventing women with cancer from losing coverage and, in some cases, life support.
It would allow insurers to charge a fee to cover a diagnosis of a cancer-related condition.
If a breast-cancer diagnosis is not diagnosed in time, a patient can get a mammogram and other medical tests, but they would be required to continue paying for treatment until they receive a diagnosis.
“If a woman’s cancer diagnosis is denied and she’s not able to receive her care, the bill will have an enormous impact on the lives of millions of women across the country,” Pritkind said.
In the United Kingdom, the average life span for a woman with a cancer diagnosis in 2020 was just over five years.
In Canada, the life span was just under five years for women diagnosed with breast- and ovarian-cancer.
The median age for a breast and ovary cancer diagnosis was about 45 years.
“This bill will make sure that every woman has access to care at the best possible time,” said British Columbia Health Minister Judy Foot.
The legislation also includes a provision that will allow the provinces to set out what kinds of breast and ova-related services patients should receive, as well as what kinds they should pay for.
“We have to remember that breast and Ova cancer are both very important cancers,” Foot said.
“This is a huge, huge deal for the health of the people of the United Kingdoms.
We have the world’s largest population, and it’s very important for us to make sure our health system is as well prepared as possible.”
Pritkind and other researchers said the benefits of the legislation would also make a difference for other types of cancers, including non-Hodgkin’s lymphoma, lymphoma and non-small cell lung cancer.
“The fact that we are getting more women diagnosed is a very encouraging sign that breast cancer is getting better, and this legislation will help,” said Pritch.
The American Cancer Society and other health groups have urged Congress to pass the legislation before the March recess, and President Donald Trump has promised to sign it.
The bill is expected to be approved in Congress on Thursday.